New business models are needed for sustainable revenue growth

The past decade has seen a substantial slowdown in the primary care market. Causes include patent expiries, the advent of generics, a reduction in launches and changes to reimbursement. Pharma companies have responded with a range of strategies, but now need to move towards a collaborative, outcome-focused model that supports healthcare delivery and health management from diagnosis to long-term care.